Ocata Therapeutics Inc  

(Public, NASDAQ:OCAT)   Watch this stock  
Find more results for OTC:ACTC
8.47
+0.01 (0.12%)
After Hours: 8.47 0.00 (0.00%)
Feb 9, 5:51PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 8.45 - 8.48
52 week 3.06 - 8.71
Open 8.47
Vol / Avg. 0.00/582,016.00
Mkt cap 358.28M
P/E     -
Div/yield     -
EPS -0.70
Shares 42.30M
Beta 0.53
Inst. own 21%

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -4564.66% -22009.72%
Operating margin -8795.92% -22249.30%
EBITD margin - -13499.45%
Return on average assets -46.18% -720.53%
Return on average equity -103.02% -
Employees 37 -
CDP Score - -

Address

33 Locke Dr
MARLBOROUGH, MA 01752-1167
United States - Map
+1-508-7561212 (Phone)
+1-508-2292333 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Ocata Therapeutics, Inc., formerly Advanced Cell Technology, Inc., is a biotechnology company focused on the development and commercialization of Regenerative Ophthalmology therapeutics. The Company's advanced products are in clinical trials for the treatment of Stargardt's macular degeneration, dry age-related macular degeneration, and myopic macular degeneration. The Company is also developing several pre-clinical terminally differentiated-cell therapies for the treatment of other ocular disorders. Additionally, it has a number of pre-clinical stage assets in disease areas outside the field of ophthalmology, including autoimmune, inflammatory and wound healing-related disorders.

Officers and directors

Michael Thomas Heffernan Independent Chairman of the Board
Age: 50
Bio & Compensation  - Reuters
Paul K. Wotton Ph.D. President, Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Edward Myles CPA Chief Financial Officer, Chief Operating Officer
Age: 43
Bio & Compensation  - Reuters
LeRoux Jooste Senior Vice President - Business Development, Chief Commercial Officer
Age: 59
Bio & Compensation  - Reuters
Robert P. Lanza M.D. Chief Scientific Officer
Age: 59
Bio & Compensation  - Reuters
John Heffernan Vice President - Manufacturing
Bio & Compensation  - Reuters
Eddy Anglade M.D. Chief Medical Officer
Age: 53
Bio & Compensation  - Reuters
Brian Levy Director
Age: 63
Bio & Compensation  - Reuters
Robert S. Langer Independent Director
Age: 66
Bio & Compensation  - Reuters
Zohar Loshitzer Independent Director
Age: 57
Bio & Compensation  - Reuters